What Biogenouest does

Biogenouest is a French non-profit Scientific Interest Group (Groupement d'Intérêt Scientifique, GIS) founded in 2002 that coordinates a network of 38 technological core facilities across Western France. These facilities span six technological axes — Bioinformatics, Genomics, Proteomics, Functional Exploration, Structural and Metabolomic Analysis, and Bio-imaging — and collectively bring together more than 400 people dedicated to technological innovation in life sciences and environmental research. The organization is headquartered in Nantes and operates regional offices, with governance provided by a Steering Committee, Scientific Council, and Animation Unit under President Aurélie Courcoul and Director Pierre Boudry.

The network's core technology is a pooled, capital-intensive instrumentation base — including next-generation sequencers, cryo-electron microscopes, mass photometers, spectral cytometers, light sheet microscopes, and NMR spectrometers — operated by qualified engineers across individual core facilities. Sub-network federating projects include GO-EV (Western France Extracellular Vesicle Network), OuestOÏD (organoid research with 3D imaging), and CatalyMar (marine biotechnology). Service offerings are grouped by axis (e.g., GenoA for sequencing, P2R/IMPACT/Protim/M.shark for proteomics, H2P2/MicroPICell/MRic/Hyperion for imaging, BIBS/Corsaire-P2M2/Phenotic for structural and metabolomics) and supplemented by a Training and Workshops Catalog and the biennial Gen2Bio congress.

The revenue model is dual-track: institutional public funding from the Bretagne and Pays de la Loire regions and national research organizations (CNRS, Inserm, INRAE), combined with service fees from academic laboratories and private companies accessing core facility equipment and expertise. Pricing is not publicly disclosed and is handled via direct inquiry and project-based quotation. Distribution is direct-to-consumer through the Biogenouest portal, with engagement also driven by event channels — Gen2Bio congress, Scientific Days, webinars, training programs, weekly newsletters, and a LinkedIn presence — targeting both academic researchers and the private biotech sector.

Name

Biogenouest

Legal name

The Biogenouest Scientific Interest Group

Website

https://biogenouest.org

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Biogenouest is a French non-profit Scientific Interest Group coordinating 38 technological core facilities across Western France, providing shared access to advanced life sciences and environmental research equipment and expertise to academic laboratories and private companies.

Ownership category

akta.pro rank

Product category

Life Sciences Research Infrastructure

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI)

akta.pro secondary industries

Organoids & Organ-on-Chip (regenerative models) (HLAAAGAD), Transcriptomics & Gene Expression Profiling Services (HLAGANAE), Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)

Keywords

• Biotech core facilities
• Life sciences research infrastructure
• Proteomics genomics services
• Bioimaging shared equipment
• Research network collaboration

Headquarters

HQ city

La Chapelle-sur-erdre

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Core Facility Services: Biogenouest core facilities provide technological services and equipment access to companies and public laboratories for research projects.
2. Scientific Interest Group Operations: Since 2002, Biogenouest has supported core facility activity as a GIS (Groupement d'Intérêt Scientifique), operating with public funding and institutional support.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Biogenouest coordinates a network of 38 technological core facilities across Western France that provide shared access to advanced equipment and qualified engineering expertise in life sciences and environmental research. The network organizes capabilities into six technological axes (Bioinformatics, Genomics, Proteomics, Functional Exploration, Structural and Metabolomic Analysis, Bio-imaging) and runs federating sub-networks such as GO-EV (extracellular vesicles) and OuestOÏD (organoids). Customers include public research laboratories and private companies seeking to outsource specialized biotech R&D infrastructure rather than acquire it in-house.

Product overview

Biogenouest is a network platform consisting of 38 technological core facilities organized into 6 scientific/technological axes: Bioinformatics, Genomics, Proteomics, Functional Exploration, Structural and Metabolomic Analysis, and Bio-imaging. The network provides shared access to advanced equipment and expertise in life sciences and environmental research for academic institutions and companies. Sub-networks include GO-EV (Extracellular Vesicles), OuestOÏD (Organoids), and Gen2Bio (Congress). Core facilities like GenoA (genomics), Protim/IMPACT/P2R (proteomics), H2P2/MicroPICell/MRic/Hyperion (bio-imaging), and Corsaire/Phenotic/BIBS (metabolomics) offer specialized services including DNA/RNA sequencing, mass spectrometry, electron microscopy, light sheet microscopy, spectral cytometry, and NMR analysis. The network also provides training workshops and scientific animation events.

Differentiator

Problem solved

Functional benefit

Brands

• GO-EV (Western France Extracellular Vesicle Network): A federating project/network within Biogenouest focused on extracellular vesicle research in Western France, with its own network of partners, events, and agenda.
• OuestOÏD

Products and services

• Biogenouest Core Facility Network
• GO-EV (Western France Extracellular Vesicle Network)

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Seven partnerships are on record, tiered core and major.

• CNRS (National Centre for Scientific Research)coreStrategic or Co-development PartnerMajor French research organization providing institutional support and scientific recognition to the GO-EV network. CNRS facilitates access to cutting-edge infrastructure and renowned experts for research projects.
• Inserm (French National Institute of Health and Medical Research)coreStrategic or Co-development PartnerFrench national institute contributing academic support and scientific expertise to the GO-EV network, facilitating research collaborations in health sciences.
• INRAE (National Research Institute for Agriculture, Food and Environment)coreStrategic or Co-development PartnerResearch institute providing infrastructure and expertise for GO-EV network activities, particularly in agricultural and environmental applications.
• Nantes University Hospital CentermajorStrategic or Co-development PartnerUniversity hospital providing clinical research perspective and access to patient samples for extracellular vesicle research applications.
• Rennes University Hospital CentermajorStrategic or Co-development PartnerUniversity hospital contributing clinical research capabilities and healthcare expertise to the GO-EV network.
• IBiSA (Informatics for Biology Integrated Structural Biology)coreStrategic or Co-development PartnerGIS IBiSA works on structuring technological core facilities at different scales, providing coordination and support for national core facility infrastructure.
• France BioImagingmajorStrategic or Co-development PartnerNational cellular imaging research infrastructure. Biogenouest H2P2, MicroPICell, and MRic core facilities form the Bretagne-Loire node of France-BioImaging.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Regional players

• ELIXIR: European bioinformatics infrastructure coordinating data resources, compute, tools, and training for life sciences across member countries. Directly parallels Biogenouest's Bioinformatics Axis (one of its 6 technological axes) at European scale.
• Euro-BioImaging ERIC: Pan-European distributed research infrastructure for biological and biomedical imaging, offering access to state-of-the-art imaging technologies across member countries. Comparable to Biogenouest's Bio-imaging Axis but operating at European geographic scale.
• EATRIS ERIC: European infrastructure for translational medicine offering biological characterization and screening services to academic and industry users. Comparable to Biogenouest's broader translational life-science service model at pan-European scale.
• Instruct-ERIC: European research infrastructure for structural biology providing access to cryo-EM, NMR, X-ray, and other techniques. Comparable to Biogenouest's Structural and Metabolomic Analysis Axis (NMR via BIBS) at a larger European footprint.

Broad incumbents

• ProFI (French Proteomics Infrastructure): National French proteomics infrastructure offering mass spectrometry–based proteomics services through coordinated core facilities. Directly comparable to Biogenouest's Proteomics Axis (Protim, IMPACT, P2R, M.shark).
• France BioImaging: French national bio-imaging infrastructure coordinated across multiple nodes, offering electron, light, and in-vivo microscopy services. It directly parallels Biogenouest's Bio-imaging Axis (H2P2, MicroPICell, MRic, Hyperion facilities) and even hosts some of the same Bretagne-Loire node institutions.
• France Génomique: National French genomics infrastructure providing sequencing and bioinformatics services through distributed core facilities. It directly parallels Biogenouest's Genomics Axis (e.g., GenoA) and Bioinformatics Axis at national rather than regional scale.
• MetaboHUB: French national metabolomics and lipidomics infrastructure providing mass spectrometry and NMR-based profiling services through distributed core facilities. Directly comparable to Biogenouest's Structural and Metabolomic Analysis Axis (BIBS, Corsaire-P2M2, Phenotic).
• CEA (Commissariat à l'énergie atomique et aux énergies alternatives): Large French public research organization with significant life-science core facility capacity across genomics, imaging, and bioinformatics as part of a much broader research portfolio (energy, defense, fundamental science). Comparable to Biogenouest's life-science modality scope but operationally broader.

Others

• IBiSA: National coordination and labeling body for life-science core facilities in biology, health, and agronomy in France. Biogenouest's facilities operate within the IBiSA-labeled ecosystem and IBiSA coordinates at national scale, comparable as an enabling infrastructure authority.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/biogenouest
• Xx.com/Biogenouest

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biogenouest